June 30, 2014 | The Israeli ultrasound developer InSightec Image Guided Treatment raised between $50-62.5 million from US investment fund York Capital, among others. InSightec is a subsidiary of Elbit Medical Technologies and has a company value $200 million before cash. GE Healthcare and Medtech are also considering investment in InSightec, a company that has developed ultrasound treatment for the removal of bone tumors. InSightec was established in 1999 and prides itself on treating tumors without invasive surgeries.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments